Please log in to view this page
Username
Password
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
